NSE ScannerTata Mutual Fund · Equity · Sectoral / Thematic · Direct plan
Tata India Pharma & Healthcare Fund - Direct Plan - Growth
₹37.7655NAV on 30 Oct 2026Expense ratio 1.07%
29 Oct 2025NAV low 32.8 · high 40.16+4.0%
In plain words
Over 3 years it returned +19.3% a year, against +7.4% for its benchmark index.
Its worst fall from a peak in the last 3 years was -16.8%.
On 3-year return it ranks 24 of 139 funds in Sectoral / Thematic.
A monthly SIP over 10 years ended ₹2,76,658 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | -1.4% | +1.9% |
| 3 months | -5.0% | -5.1% |
| 6 months | +6.9% | -3.2% |
| 1 year | +4.3% | -10.2% |
| 3 years (yearly) | +19.3% | +7.4% |
| 5 years (yearly) | +14.9% | +6.5% |
| 10 years (yearly) | +14.6% | +11.3% |
| Since start (yearly) | +13.0% | +11.2% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,25,184 | +7.1% |
| 3 years | ₹3,60,000 | ₹4,21,893 | +10.1% |
| 5 years | ₹5,90,000 | ₹8,81,949 | +15.9% |
| 10 years | ₹11,90,000 | ₹30,35,796 | +17.8% |
Other plan of this fund: Tata India Pharma & Healthcare Fund - Regular Plan - Growth